NorthWest Biotherapeutics Inc (NWBO): 10-K EXHIBIT A SUB-LEASED AREA https:...

Send PM Follow Ignore

Followers	113
Posts	1863
Boards Moderated	0
Alias Born	11/22/2017

Lykiri

Re: j e d post# 572169

Tuesday, 02/28/2023 7:41:15 PM

Tuesday, February 28, 2023 7:41:15 PM

10-K
EXHIBIT A
SUB-LEASED AREA
https://www.sec.gov/Archives/edgar/data/1072379/000141057822000244/nwbo-20211231xex10d87.htm
Phase 1B

Unfinished and/or un-equipped interior space:

Hotel Suite 3 = 2,012 ft2
Hotel Suite 4 = 2,012 ft2
Nitrogen cryostorage area = 2,560 ft2
Plant room + electrical cupboard = 1,300 ft2
Sub-Total: 7,884 ft2

Hotel Suites = manufacturing suites.

"The buildout of Phase 1A of the Sawston facility was previously completed, and the buildout of Phase 1B has been under way in 2022 and Q1 of 2023."

"Phase 1B is expected to be completed and placed in use by approximately the end of Q2 2023."

https://www.sec.gov/ix?doc=/Archives/edgar/data/1072379/000141057823000185/nwbo-20221231x10k.htm
Phase 1A

Finished and equipped interior space:

Hotel Suite 1 (including C lab extension) = 2,238 ft2
Hotel suite 2 = 2,012 ft2
Labs (PD and QC) = 830 ft2
Corridors = 1,420 ft2
Computer room = 75 ft2

Sub-Total = 6,575 ft2